These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2865868)

  • 21. Clinical practice. Generalized anxiety disorder.
    Fricchione G
    N Engl J Med; 2004 Aug; 351(7):675-82. PubMed ID: 15306669
    [No Abstract]   [Full Text] [Related]  

  • 22. Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
    Draper RJ; Daly I
    Ir Med J; 1983 Nov; 76(11):453-6. PubMed ID: 6139353
    [No Abstract]   [Full Text] [Related]  

  • 23. Separation of anxiety and depressive disorders: normal rules of critical evaluation were presumably suspended.
    Weeks RL
    BMJ; 2003 Oct; 327(7419):869; author reply 870. PubMed ID: 14551115
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling anxiety and depression.
    Mynatt S; Cunningham P
    Nurse Pract; 2007 Aug; 32(8):28-36; CEU quiz 36-7. PubMed ID: 17667764
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR
    J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological management of anxiety in patients suffering from schizophrenia].
    Baylé FJ; Blanc O; De Chazeron I; Lesturgeon J; Lançon C; Caci H; Garay RP; Llorca PM
    Encephale; 2011 May; 37 Suppl 1():S83-9. PubMed ID: 21600338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separation of anxiety and depressive disorders: New tools will lead to more valid classification system.
    First MB; Regier DA
    BMJ; 2003 Oct; 327(7419):869-70; author reply 870. PubMed ID: 14551116
    [No Abstract]   [Full Text] [Related]  

  • 29. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of benzodiazepines in the treatment of depression].
    Escande M; Granier F; Girard M
    Encephale; 1983; 9(4 Suppl 2):273B-277B. PubMed ID: 6144524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meeting the challenge of generalized anxiety disorder.
    Buskey RN
    JAAPA; 2004 Dec; 17(12):19-22, 24. PubMed ID: 15631017
    [No Abstract]   [Full Text] [Related]  

  • 32. A case report of alprazolam-induced stuttering.
    Elliott RL; Thomas BJ
    J Clin Psychopharmacol; 1985 Jun; 5(3):159-60. PubMed ID: 2860135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression.
    Imlah NW
    Br J Psychiatry; 1985 May; 146():515-9. PubMed ID: 2861873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Newcastle rating scales.
    Roth M; Gurney C; Mountjoy CQ
    Acta Psychiatr Scand Suppl; 1983; 310():42-54. PubMed ID: 6582770
    [No Abstract]   [Full Text] [Related]  

  • 36. [49. Phobic disorder, panic or generalized anxiety? Basic principles in diagnosis and therapy].
    Möller HJ
    MMW Fortschr Med; 2003 Nov; 145(47):I-VIII; quiz IX-X. PubMed ID: 14725047
    [No Abstract]   [Full Text] [Related]  

  • 37. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW; Jue SG; Brogden RN
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiety disorders in late life.
    Flint AJ
    Can Fam Physician; 1999 Nov; 45():2672-9. PubMed ID: 10587775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam in the treatment of neurotic anxiety.
    Kerry RJ; McDermott CM
    Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of depression and anxiety in Parkinson's disease.
    Mercury MG; Tschan W; Kehoe R; Kuechler A
    Dis Mon; 2007 May; 53(5):296-301. PubMed ID: 17656191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.